Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines

Doxorubicin (DOX) is widely used in both human and veterinary oncology although the onset of multidrug resistance (MDR) in neoplastic cells often leads to chemotherapy failure. Better understanding of the cell...

Source: BMC Veterinary Research - January 18, 2021 Category: Veterinary Research Authors: Michela Levi, Roberta Salaroli, Federico Parenti, Raffaella De Maria, Augusta Zannoni, Chiara Bernardini, Cecilia Gola, Antonio Brocco, Asia Marangio, Cinzia Benazzi, Luisa Vera Muscatello, Barbara Brunetti, Monica Forni and Giuseppe Sarli Tags: Research article Source Type: research